Therefore, we, for the first time, disclosed that transcription of AGT in breast cancer cells was subjected to the negative regulatory action of glucose concentration, which might consequently underlie the pro-tumoral activities of high glucose in breast cancer cells. The gene discussed is AGT; the disease is breast cancer.